User profiles for Rana Gbyli
Rana GbyliYale University Verified email at yale.edu Cited by 768 |
A neutrophil activation signature predicts critical illness and mortality in COVID-19
Pathologic immune hyperactivation is emerging as a key feature of critical illness in COVID-19,
but the mechanisms involved remain poorly understood. We carried out proteomic …
but the mechanisms involved remain poorly understood. We carried out proteomic …
Circulating markers of angiogenesis and endotheliopathy in COVID-19
Increase in thrombotic and microvascular complications is emerging to be a key feature of
patients with critical illness associated with COVID-19 infection. While endotheliopathy is …
patients with critical illness associated with COVID-19 infection. While endotheliopathy is …
Achieving totally local anticoagulation on blood contacting devices
R Gbyli, A Mercaldi, H Sundaram… - Advanced Materials …, 2018 - Wiley Online Library
The recent years have witnessed an increased activity in biocompatibility research aimed at
limiting biomaterial‐induced blood coagulation. From 2008 to 2016, a total of $36 946 …
limiting biomaterial‐induced blood coagulation. From 2008 to 2016, a total of $36 946 …
[PDF][PDF] m6A modification prevents formation of endogenous double-stranded RNAs and deleterious innate immune responses during hematopoietic development
N 6 -methyladenosine (m 6 A) is the most abundant RNA modification, but little is known
about its role in mammalian hematopoietic development. Here, we show that conditional …
about its role in mammalian hematopoietic development. Here, we show that conditional …
[HTML][HTML] A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies
Comprehensive preclinical studies of Myelodysplastic Syndromes (MDS) have been elusive
due to limited ability of MDS stem cells to engraft current immunodeficient murine hosts. …
due to limited ability of MDS stem cells to engraft current immunodeficient murine hosts. …
Combined liver–cytokine humanization comes to the rescue of circulating human red blood cells
In vivo models that recapitulate human erythropoiesis with persistence of circulating red
blood cells (RBCs) have remained elusive. We report an immunodeficient murine model in …
blood cells (RBCs) have remained elusive. We report an immunodeficient murine model in …
Humanized mice as preclinical models for myeloid malignancies
Humanized mice have proven to be invaluable for human hematological translational research
since they offer essential tools to dissect disease biology and to bridge the gap between …
since they offer essential tools to dissect disease biology and to bridge the gap between …
In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2
Abstract Treatment options for patients with relapsed/refractory acute myeloid leukemia (AML)
and myelodysplastic syndromes (MDS) are scarce. Recurring mutations, such as …
and myelodysplastic syndromes (MDS) are scarce. Recurring mutations, such as …
[PDF][PDF] Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies
Splicing factor mutations are common among cancers, recently emerging as drivers of myeloid
malignancies. U2AF1 carries hotspot mutations in its RNA-binding motifs; however, how …
malignancies. U2AF1 carries hotspot mutations in its RNA-binding motifs; however, how …
[HTML][HTML] Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes
Abstract Treatment for myelodysplastic syndromes (MDS) remains insufficient due to clonal
heterogeneity and lack of effective clinical therapies. Dysregulation of apoptosis is observed …
heterogeneity and lack of effective clinical therapies. Dysregulation of apoptosis is observed …